These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34898146)

  • 21. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris.
    Kakita L
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S51-4. PubMed ID: 10898831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term safety and efficacy study of adapalene 0.3% gel.
    Weiss JS; Thiboutot DM; Hwa J; Liu Y; Graeber M
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s24-8. PubMed ID: 18575223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial.
    Poulin Y; Sanchez NP; Bucko A; Fowler J; Jarratt M; Kempers S; Kerrouche N; Dhuin JC; Kunynetz R
    Br J Dermatol; 2011 Jun; 164(6):1376-82. PubMed ID: 21457209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris.
    Pariser DM; Westmoreland P; Morris A; Gold MH; Liu Y; Graeber M
    J Drugs Dermatol; 2007 Sep; 6(9):899-905. PubMed ID: 17941361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
    Thiboutot D; Gold MH; Jarratt MT; Kang S; Kaplan DL; Millikan L; Wolfe J; Loesche C; Baker M
    Cutis; 2001 Oct; 68(4 Suppl):10-9. PubMed ID: 11845943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
    Pariser D; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s18-23. PubMed ID: 18575222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
    Capizzi R; Landi F; Milani M; Amerio P
    Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety.
    Eichenfield LE; Jorizzo JL; Dirschka T; Taub AF; Lynde C; Graeber M; Kerrouche N
    J Drugs Dermatol; 2010 Nov; 9(11):1395-401. PubMed ID: 21061762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differin (adapalene) Gel, 0.3%.
    Abramovits W; Gupta A
    Skinmed; 2007; 6(6):287-8. PubMed ID: 17975346
    [No Abstract]   [Full Text] [Related]  

  • 30. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%.
    Zhang JZ; Li LF; Tu YT; Zheng J
    J Dermatolog Treat; 2004 Dec; 15(6):372-8. PubMed ID: 15764049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of combined topical treatment of acne vulgaris with adapalene and nadifloxacin: a randomized study.
    Kobayashi M; Nakagawa T; Fukamachi K; Nakamura M; Tokura Y
    J Dermatol; 2011 Dec; 38(12):1163-6. PubMed ID: 22007904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.
    Webster GF; Guenther L; Poulin YP; Solomon BA; Loven K; Lee J
    Cutis; 2002 Feb; 69(2 Suppl):4-11. PubMed ID: 12095066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study.
    Thiboutot DM; Shalita AR; Yamauchi PS; Dawson C; Arsonnaud S; Kang S;
    Skinmed; 2005; 4(3):138-46. PubMed ID: 15891249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
    Maiti R; Sirka CS; Ashique Rahman MA; Srinivasan A; Parida S; Hota D
    Clin Drug Investig; 2017 Nov; 37(11):1083-1091. PubMed ID: 28913735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Digital videography assessment of patients' experiences using adapalene-benzoyl peroxide gel in the treatment of acne vulgaris.
    Feldman SR; Fried RG; Herndon JH; Johnson L; Preston N; Gottschalk RW; Caveney SW
    J Drugs Dermatol; 2012 Aug; 11(8):919-25. PubMed ID: 22859236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.
    Thiboutot DM; Weiss J; Bucko A; Eichenfield L; Jones T; Clark S; Liu Y; Graeber M; Kang S;
    J Am Acad Dermatol; 2007 Nov; 57(5):791-9. PubMed ID: 17655969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris.
    Ellis CN; Millikan LE; Smith EB; Chalker DM; Swinyer LJ; Katz IH; Berger RS; Mills OH; Baker M; Verschoore M; Loesche C
    Br J Dermatol; 1998 Oct; 139 Suppl 52():41-7. PubMed ID: 9990420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.
    Thiboutot DM; Shalita AR; Yamauchi PS; Dawson C; Kerrouche N; Arsonnaud S; Kang S
    Arch Dermatol; 2006 May; 142(5):597-602. PubMed ID: 16702497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The results of the MORE trial: overview.
    Campbell JL; Weiss JS
    Cutis; 2006 Jul; 78(1 Suppl):5-11. PubMed ID: 16910025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MORE trial: effectiveness of adapalene gel 0.1% in real-world dermatology practices.
    Gold LS
    Cutis; 2006 Jul; 78(1 Suppl):12-8. PubMed ID: 16910026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.